EPISODE · Jan 21, 2026 · 20 MIN
Herantis’s ‘Elegant’ Approach In Parkinson’s
from Citeline Podcasts · host Norstella
Antti Vuolanto, CEO of Herantis Pharma, discusses the significant unmet need in Parkinson’s disease and outlines Phase II plans for the company’s lead asset HER-096.
What this episode covers
Antti Vuolanto, CEO of Herantis Pharma, discusses the significant unmet need in Parkinson’s disease and outlines Phase II plans for the company’s lead asset HER-096.
NOW PLAYING
Herantis’s ‘Elegant’ Approach In Parkinson’s
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m